XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Business combination and PIPE [Member]
Previously Reported [Member]
Revision of Prior Period, Adjustment [Member]
Convertible Preferred Stock [Member]
Convertible Preferred Stock [Member]
Previously Reported [Member]
Convertible Preferred Stock [Member]
Revision of Prior Period, Adjustment [Member]
Common Stock [Member]
Common Stock [Member]
Business combination and PIPE [Member]
Common Stock [Member]
Previously Reported [Member]
Common Stock [Member]
Revision of Prior Period, Adjustment [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Business combination and PIPE [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Revision of Prior Period, Adjustment [Member]
Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Previously Reported [Member]
Beginning balance at Dec. 31, 2019           $ 79,204 $ (79,204)                      
Beginning balance, Shares at Dec. 31, 2019           8,606,780 (8,606,780)                      
Beginning balance at Dec. 31, 2019 $ 48,604   $ 48,604         $ 15   $ 9 $ 6 $ 84,103   $ 4,905 $ 79,198   $ (35,514) $ (35,514)
Beginning balance, Shares at Dec. 31, 2019               151,014,472   8,031,018 142,983,454              
Share-based compensation 881                     881            
Issuance of common stock upon exercise of stock options 5                     5            
Issuance of common stock upon exercise of stock options, Shares               83,732                    
Net loss (6,852)                               (6,852)  
Ending balance at Mar. 31, 2020                                  
Ending balance, Shares at Mar. 31, 2020         0                          
Ending balance at Mar. 31, 2020 42,638             $ 15       84,989         (42,366)  
Ending balance, Shares at Mar. 31, 2020               151,098,204                    
Beginning balance at Dec. 31, 2020           $ 79,204 $ (79,204)                      
Beginning balance, Shares at Dec. 31, 2020           8,606,780 (8,606,780)                      
Beginning balance at Dec. 31, 2020 26,913   $ (52,291) $ 79,204       $ 15   $ 9 $ 6 87,982   $ 8,784 $ 79,198 $ 0 (61,084) $ (61,084)
Beginning balance, Shares at Dec. 31, 2020               151,365,509   8,069,693 143,295,816              
Share-based compensation 4,513                     4,513            
Issuance of common stock upon exercise of stock options $ 198                     198            
Issuance of common stock upon exercise of stock options, Shares 701,139             701,139                    
Business combination and PIPE financing, net of acquired private placement warrant   $ 557,763             $ 6       $ 557,757          
Business combination and PIPE financing, net of acquired private placement warrant, Shares                 59,343,104                  
Offering cost in connection with Business combination and PIPE financing   $ (47,983)                     $ (47,983)          
Issuance of common stock upon release of restricted stock units, Shares               41,408                    
Unrealized loss on available-for-sale securities $ (29)                             (29)    
Net loss (19,458)                               (19,458)  
Ending balance at Mar. 31, 2021         $ 0                          
Ending balance, Shares at Mar. 31, 2021         0                          
Ending balance at Mar. 31, 2021 $ 521,917             $ 21       $ 602,467       $ (29) $ (80,542)  
Ending balance, Shares at Mar. 31, 2021               211,451,160